Abstract:Metabolomics has emerged as a mainstream approach for investigating complex metabolic phenotypes but has yet to be integrated into routine clinical diagnostics. Metabolomics-based diagnosis of urinary tract infections (UTIs) is a logical application of this technology since microbial waste products are concentrated in the bladder and thus could be suitable markers of infection. We conducted an untargeted metabolomics screen of clinical specimens from patients with suspected UTIs and identified two metabolites, agmatine and N6-methyladenine, that are predictive of culture positive samples. We developed a 3.2-minute LC-MS assay to quantify these metabolites and showed that agmatine and N6-methyladenine correctly identify UTIs caused by 13 Enterobacterales species and 3 non-Enterobacterales species, accounting for over 90% of infections (agmatine AUC > 0.95; N6-methyladenine AUC > 0.89). These markers were robust predictors across two blinded cohorts totaling 1,629 patient samples. These findings demonstrate the potential utility of metabolomics in clinical diagnostics for rapidly detecting UTIs.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is: how to use metabolomics techniques to quickly and accurately diagnose urinary tract infections (UTIs). Specifically, the authors hope to find biomarkers that can distinguish whether there are pathogenic bacteria in urine samples through metabolomics methods, so as to achieve rapid diagnosis without culturing. ### Research background and problems 1. **Limitations of traditional diagnostic methods**: - Currently, the diagnosis of urinary tract infections mainly depends on patients' symptoms and laboratory bacterial culture tests. These tests usually require more than 18 hours of culturing time, resulting in a long diagnosis cycle. - Due to the delay in diagnosis, doctors often prescribe antibiotics without laboratory results, which may lead to the overuse of antibiotics and further promote the spread of drug - resistant bacteria. 2. **Advantages of metabolomics**: - Microbial metabolites in urine (such as amine compounds) can be used as potential biomarkers for rapid detection of urinary tract infections. - Through liquid chromatography - mass spectrometry (LC - MS) analysis, these metabolites can be detected in a short time, thus achieving rapid diagnosis. ### Research objectives The main objectives of this study are: - **Systematic analysis**: Through non - targeted metabolomics analysis of urine samples from patients suspected of having urinary tract infections, identify metabolites with sufficient predictive ability to support a rapid, metabolism - based diagnostic method. - **Validate biomarkers**: Validate the effectiveness of the discovered biomarkers in clinical diagnosis through two independent blinded cohorts (a total of 1,629 patient samples). ### Main findings 1. **Discover biomarkers**: - Through non - targeted metabolomics analysis, the researchers discovered two metabolites - agmatine and N6 - methyladenine. Their concentrations in urine are closely related to urinary tract infections. - These two metabolites have relatively high predictive abilities for different types of urinary tract infection pathogens respectively: - **agmatine** has a high predictive ability for infections caused by Enterobacterales (AUC > 0.95). - **N6 - methyladenine** has a relatively good predictive ability for infections caused by a few non - Enterobacterales pathogens (such as Staphylococcus aureus, Staphylococcus saprophyticus, etc.) (AUC > 0.89). 2. **Develop a rapid detection method**: - The researchers developed a 3.2 - minute LC - MS detection method for the quantitative analysis of these two metabolites and demonstrated its high accuracy in two independent cohorts. ### Conclusion This study shows the potential of metabolomics in the clinical diagnosis of urinary tract infections, especially in shortening the diagnosis time by rapidly detecting specific metabolites in urine, which is helpful for more precise use of antibiotics and reducing unnecessary drug treatment. However, the study also points out some limitations. For example, metabolic markers cannot completely replace traditional bacterial culture and antimicrobial susceptibility testing, especially in the diagnosis of complex or hospitalized patients.

Metabolomics strategy for diagnosing urinary tract infections

Application of MALDI-TOF MS for identifying bacteria directly in midstream urine samples

The Role of Metabolomics and Microbiology in Urinary Tract Infection

Metabolomics survey of uropathogenic bacteria in human urine

Diagnosing inflammation and infection in the urinary system via proteomics

Urinary Tract Infections Detection with Molecular Biomarkers

Sniffing Out Urinary Tract Infection—Diagnosis Based on Volatile Organic Compounds and Smell Profile

Analytical Validation of a Highly Accurate and Reliable Next-Generation Sequencing-Based Urine Assay

Urinary biochemical ecology reveals microbiome-metabolite interactions and metabolic markers of recurrent urinary tract infection

Urine biomarkers individually and as a consensus model show high sensitivity and specificity for detecting UTIs

Metatranscriptomics-based metabolic modeling of patient-specific urinary microbiome during infection

LC-SRM combined with machine learning enables fast identification and quantification of bacterial pathogens in urinary tract infections

Identification of Enterococcus faecalis in a patient with urinary-tract infection based on metagenomic next-generation sequencing: a case report

Gram-Stain Plus MALDI-TOF MS (Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry) for a Rapid Diagnosis of Urinary Tract Infection

Rapid Identification and Antimicrobial Susceptibility Testing for Urinary Tract Pathogens by Direct Analysis of Urine Samples Using a MALDI-TOF MS-Based Combined Protocol

Enhancing urinary tract infection diagnosis for negative culture patients with metagenomic next-generation sequencing (mNGS)

Exploratory urinary metabolic biomarkers and pathways using UPLC-Q-TOF-HDMS coupled with pattern recognition approach

A novel approach to screening and managing the urinary tract infections suspected sample in the general human population

Application of metagenomic next-generation sequencing in the diagnosis of urinary tract infection in patients undergoing cutaneous ureterostomy

Rapid Identification of Bacterial Mixtures in Urine Using MALDI-TOF MS-based Algorithm Profiling Coupled with Magnetic Enrichment